3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Thyroid Neoplasms
2
Esophageal Neoplasms
2
Stereotactic Body Radiation Therapy
1
Lung Neoplasms
1
Liver Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
anlotinib
1
Angiogenesis Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Stereotactic Body Radiation Therapy
×
anlotinib
×
Clear all
NCT04912128
2021-06-03
AnloSBRT
Peking University Third Hospital
Completed
30 enrolled